Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +22.98%
#3 Audiera Audiera +21.36%
#4 Velvet Velvet +19.74%
#5 Biconomy Biconomy +17.74%
#6 Geodnet Geodnet +16.44%
#7 aPriori aPriori +13.80%
#8 Quack AI Quack AI +13.49%
#9 Cross Cross +13.44%
#10 Humanity Humanity +11.22%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Tissue Repair Ltd Tissue Repair Ltd

Tissue Repair Ltd

TRP
Rangering i aksjer #35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Aksjekurs
$0.05994921
Sist synkronisert: 2026-08-13
Markedsverdi
$3.62M
Endring (1 dag)
-1.16%
Endring (1 år)
-66.49%
Land
AU
Handel Tissue Repair Ltd (TRP)

Kategori

Healthcare
Inntekter for Tissue Repair Ltd (TRP)
Inntekter i 2026 TTM: 0
Ifølge Tissue Repair Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Tissue Repair Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE